The FDA has “proactively” granted Johnson & Johnson a coveted speedy review under the Commissioner’s National Priority Voucher pilot (CNPV), the agency said Monday. The voucher was granted to J&J for ...
Sanofi SAN-0.59%decrease; red down pointing triangle shares fell after an experimental treatment for multiple sclerosis was hit by a double setback, with results of a late-stage study missing a key ...
INDEPENDENCE, Wis. (WKBT) — A Whitehall man faces serious charges after a 14-month-old child was found with multiple broken bones throughout her body, according to criminal charges filed Thursday in ...
WAXHAW, N.C. — The Waxhaw Police Department has arrested a 55-year-old man in connection with a child sexual abuse investigation. Officers said Carl Valentin IV was taken into custody Thursday morning ...
Dec 10 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...
Hosted on MSN
Montezuma man charged with multiple counts of sexual abuse, violating sex offender registration
Jacob Thompson was previously convicted in 2008 for assault with intent to commit sexual abuse and in 2013 for sexual exploitation of a minor. What happened with the 14th Amendment? Abandoned vessel ...
(RTTNews) - Exicure, Inc. (XCUR) skyrocketed 41.37%, adding $2.18 to trade at $7.45, after the company announced positive topline results from its Phase 2 study of burixafor in multiple myeloma. The ...
A new study has found that substance use disorders (SUD) cost the U.S. economy just under $93 billion in 2023 from a combination of missed work, reduced work productivity and lost household ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Comeback stories are often the stuff of movies, but GSK is showing they can also happen in pharmaceuticals. The multiple myeloma medicine Blenrep has returned to the market three years after GSK ...
Dr. Robert Orlowski says a single-drug option in newly diagnosed myeloma may offer strong responses with fewer side effects and preserve future treatments. Dr. Robert Orlowski presented updated ELARA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback